Final efficacy, safety and biomarker results of the phase 2b/3 randomized, double-blinded, placebo-controlled early trial of atabecestat in preclinical alzheimer’s diseaseDavid Henley,Reisa A. Sperling,Paul S. Aisen,Rema Raman,Michael C. Donohue,Karin Ernstrom,Yingqi Shi,Keith Karcher,Nandini Raghavan,Yevgen Tymofyeyev,Robert Brashear,Gerald P. Novak,John Thipphawong,Ziad Saad,Hartmuth C. Kolb,Gary RomanoAlzheimers & Dementia（2019）引用 1|浏览49暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
